The CDC panel votes for Nix current recommendations for cocvid vaccine

On Friday, the Consultative Committee on Vaccination Practices (ACIP) voted to abandon its recommendation that American adults should generally receive the COVVI-19 vaccine, rather approving an individual approach.

In a unanimous decision, members of the AICP have agreed that adults aged 65 and over should decide on themselves or with their doctor if he had to be vaccinated for COVID-19. The AIPI has also recommended that people aged 6 months and 64 will make an individual decision concerning COVVI-19 vaccination (yes, you read it correctly), while being informed that the advantages of vaccination are the most obvious in people who are more at risk of serious illness.

The APIP has narrowly avoided by recommending that the Americans should need a prescription to get the covid-19, but barely.

A chaotic ACIP meeting

The votes closed a chaotic and disorganized discussion held on Friday on the safety and efficiency of COVVI-19 mRNA vaccines.

Retsef Levi, long-standing skeptical of COVVI-19 vaccines and operations management professor at MIT Sloan School of Management, led the APIP discussion, as well as the working group on COVVI-19 vaccines. Levi is one of the many members of the ACIP with the Secretary of Health, Robert Kennedy Jr.

CDC staff have presented evidence trains that COVVI-19 vaccines, even today, still prevent serious results such as hospitalization and death, including in very young children. Many external experts have also testified to support the maintenance of generalized access to these vaccines for each American who wants them. But members of the APIP have often called into question the conclusions or made their own attempts badly practiced to attack the security of the vaccines.

At a given time, for example, members of the AIPI supported a pretending article to show in -depth contamination of the DNA of vaccines – a study that external experts criticized for flagrant defects and which is now being examined in relation to the potential concerns of his publisher. At another time, members argued that COVVI-19 vaccines could possibly increase the risk of cancer, a complaint largely refuted by most experts (technology of mRNA vaccines is actively studied as a means of preventing and treating certain cancers).

What this vote means for access to the covented vaccine

The language of the votes Aipti today has only been disclosed at the very last minute, and it is not quite clear how they will have an impact on access to vaccines.

At the end of last month, Food and Drug Administration limited its explicit approval of Boosters updated COVID-19 to people over 65 or those who have a higher risk of serious illness. The recommendation of the AIPI to move to an individualized approach, assuming that it is adopted by the CDC, can delay or prevent people from obtaining a Booster COVID-19 if they choose it.

That said, several states like New York have already taken measures to ensure continuous access to the vaccine and public coverage of the vaccine to all their residents. This week, the country’s largest health insurance association, America’s Health Insurance Plans, also announced that its members would rely on the previous recommendations of the AIPI to determine their coverage of the COVVI-19 vaccine at the moment. He also said that patients covered by these plans would not suffer costs until the end of 2026.

In a vote of 6 to 6, the ACIP refused to approve a recommendation calling people to demand an order for COVVI -19 vaccines – the president of the AIPI, Martin Kulldorff, published the equality break, voting “no”.